QULIPTA

Abbvie Corporation🇨🇦 Health Canada

Approval Id: 444ed4d85441ff2c
Drug Approval Canada Name: QULIPTA
Product Name: QULIPTA
Status: Marketed
Status Date: 2023-03-24
Original Market Date: 2023-03-24
Din: 02533979
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:32.12
Atc Original: N02CD07 ATOGEPANT
Atc Name: n 02 cd 07
Aig Number: 0164361001
Company Name: Abbvie Corporation
Company Address: 8401 Trans-Canada Highway, Saint-Laurent, Quebec, Canada, H4S 1Z1
Company Detail Path: /organization/abbvie-corporation

ATOGEPANT

10 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

444ed4d85441ff2c

Type

Standard